Call Us08045479576
Levocetirizine Dihydrochloride

Levocetirizine Dihydrochloride

25.00 - 50.00 INR/Kilograms

Product Details:

  • Molecular Weight 461.8 g/mol Grams (g)
  • Storage Room Temperature
  • Molecular Formula C21H27Cl3N2O3
  • Medicine Name Levocetirizine Dihydrochloride
  • Type Pharmaceutical Intermediates
  • Grade Medicine Grade
  • Purity(%) 98%
  • Click to View more
X

Levocetirizine Dihydrochloride Price And Quantity

  • 25.00 - 50.00 INR/Kilograms
  • 25 Kilograms

Levocetirizine Dihydrochloride Product Specifications

  • 98%
  • C21H27Cl3N2O3
  • Pharmaceutical Intermediates
  • Powder
  • Levocetirizine Dihydrochloride
  • 461.8 g/mol Grams (g)
  • Medicine Grade
  • Room Temperature

Levocetirizine Dihydrochloride Trade Information

  • Cash in Advance (CID) Cash Advance (CA)
  • 1000 Kilograms Per Day
  • 7 Days
  • Australia Eastern Europe Western Europe Middle East Africa Central America South America Asia North America

Product Description

The third-generation antihistamine levocetirizine, marketed as Xyzal, is used for the treatment of allergic rhinitis and hives of unknown cause. Compared to older antihistamines, it is less sedating. The drug works by blocking an allergic reaction-triggering chemical (histamine). There is no evidence to suggest levocetirizine prevents or treats hives, anaphylaxis, or other severe allergies.


Properties:
  • CAS ID: 130018-77-8
  • Molecular Formula: C21H27Cl3N2O3
  • Molecular weight : 461.8
  • Boiling point: 542.1 C
  • Melting Point: 214 C
  • Synonyms : (R)-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl] ethoxy] 
  • Solubility: Freely soluble in water

How does it work:

Levocetirizine belongs to the class of medications called antihistamines. As a result, it blocks the effect of histamine, which is the cause of allergic symptoms. As an antihistamine, levocetirizine is used to treat symptoms such as watery eyes, runny noses, itchy eyes and noses, and sneezing due to allergies. Additionally, it is used to relieve itching and hives. 

Applications Or where it is used:

During an allergic reaction, your body makes a substance called histamine which is blocked by the drug. Levocetirizine does not prevent or treat hives or severe allergic reactions (such as anaphylaxis). Keep your epinephrine injector handy if you have been prescribed it to treat allergic reactions. Use epinephrine instead of levocetirizine.

How to use:

You should take this medication by mouth once a day in the evening, with or without food. You must measure the dose carefully if you are using the liquid form of this medication. A household spoon may not deliver the correct dose.

Dosage of usage:
  • You should take the medication according to your age, the condition you are treating, how severe the condition is, and how you react to the first dose. An adult typically takes one 5-mg tablet once every evening.
  • Special dosage considerations: Mild kidney disease: 2.5 mg once per day. 
  • Moderate kidney disease: 2.5 mg once every other day. 
  • Severe kidney disease: 2.5 mg twice per week (taken once every 34 days).
Side effects:

You may feel drowsy, tired, and have a dry mouth. It is also possible to have a fever, especially in children. Your doctor or pharmacist should be notified right away if any of these side effects persist or worsen. An allergic reaction is very rare with this medication. Get medical help if any of the following symptoms occur: rash, itchy/swelling, difficulty breathing and severe dizziness.

Warnings and precautions while using this product:

Levocetirizine should not be used by people allergic to it or to cetirizine (Zyrtec). Dialysis patients or those with end-stage kidney disease should not take levocetirizine. Levocetirizine is not recommended for children younger than 12 years old with kidney disease. Breast-feeding is not recommended while you are using this medication. Children younger than 6 months old should not use levocetirizine.
Tell us about your requirement
product

Levocetirizine Dihydrochloride

Quantity
Select Unit

  • 50
  • 150
  • 300
  • 500
  • 750
  • 1050
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category